文献速递心脑血管急症重症综合管理与镇静镇痛

脑脊液泛素羧基末端酯酶L1蛋白对目标温度管理后心脏骤停患者神经预后的预测价值

The value of cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 protein as a prognostic predictor of neurologic outcome in post-cardiac arrest patients treated with targeted temperature management.
PubMed 文献 · Resuscitation · 2020-04-06
一句话结论在院外心脏骤停后接受目标温度管理的患者中,脑脊液UCHL1在ROSC后即刻、24、48、72小时均可预测神经预后不良,血清UCHL1在24、48、72小时也有显著预测价值。

该研究为前瞻性单中心观察性队列研究,纳入38例院外心脏骤停后接受目标温度管理的患者,其中16例神经预后不良。在ROSC后即刻、24、48、72小时分别检测血清和脑脊液UCHL1,用AUROC和Delong法确定预测神经预后的截断值。脑脊液UCHL1各时间点AUROC分别为0.93、0.91、0.97、0.98,血清UCHL1分别为0.71、0.85、0.90、0.94;即刻时间点两者AUROC差异有统计学意义(p=0.01)。作者认为脑脊液UCHL1各时间点均为有价值的预测指标,血清UCHL1在24、48、72小时对预后不良有显著预测性能。

要点

  • 脑脊液UCHL1在ROSC后即刻、24、48、72小时预测神经预后不良的AUROC分别为0.93、0.91、0.97、0.98。
  • 血清UCHL1在ROSC后即刻、24、48、72小时预测神经预后不良的AUROC分别为0.71、0.85、0.90、0.94。
  • ROSC后即刻脑脊液UCHL1的AUROC(0.93)显著高于血清UCHL1(0.71),p=0.01。
  • 24、48、72小时脑脊液与血清UCHL1的AUROC差异均未达统计学显著(p=0.24、0.07、0.25)。
  • 研究共纳入38例院外心脏骤停后接受目标温度管理的患者,其中16例神经预后不良。

适用人群与场景

  • 院外心脏骤停后复苏成功并接受目标温度管理的成人患者,来自单中心前瞻性观察性队列,2018年4月至2019年9月纳入。

研究设计与关键结果

  • 前瞻性单中心观察性队列研究,纳入38例院外心脏骤停后接受目标温度管理的患者,其中16例神经预后不良。
  • 在ROSC后即刻、24、48、72小时检测血清和脑脊液UCHL1,用AUROC和Delong法确定预测神经预后的截断值。
  • 脑脊液UCHL1各时间点AUROC:即刻0.93、24小时0.91、48小时0.97、72小时0.98。
  • 血清UCHL1各时间点AUROC:即刻0.71、24小时0.85、48小时0.90、72小时0.94。
  • 即刻时间点脑脊液与血清UCHL1的AUROC差异有统计学意义(p=0.01);24、48、72小时差异均未达统计学显著(p=0.24、0.07、0.25)。

证据类型、等级与局限

  • 证据类型:前瞻性单中心观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脑脊液UCHL1在ROSC后即刻、24、48、72小时测定是评估神经预后的有价值预测指标。
  • 作者认为,血清UCHL1在ROSC后24、48、72小时测定对目标温度管理后院外心脏骤停患者的预后不良显示出显著预测性能。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: We evaluated the prognostic value of serum- and cerebrospinal fluid (CSF)-ubiquitin carboxyl-terminal esterase L1 protein (UCHL1) measurements in post- post-out of hospital cardiac arrest (OHCA) patients treated with target temperature management (TTM), to predict neurologic outcome.

METHODS: This was a prospective single-centre observational cohort study, conducted from April 2018 to September 2019. Serum- and CSF-UCHL1 were obtained immediately (UCHL1initial), 24 h (UCHL124), 48 h (UCHL148), and 72 h (UCHL172) after return of spontaneous circulation (ROSC). The area under the receiver operating characteristic curves (AUROC) and Delong method were used to identify cut-off values of serum- and CSF-UCHL1initial, UCHL124, UCHL148, UCHL172 for predicting neurologic outcomes.

RESULTS: Of 38 patients enrolled, 16 comprised the poor outcome group. The AUROCs for serum- and CSF-UCHL1initial were 0.71 and 0.93 in predicting poor neurological outcomes, respectively (p = 0.01). The AUROCs for serum- and CSF-UCHL124 were 0.85 and 0.91 (p = 0.24). The AUROCs for serum- and CSF-UCHL148 were 0.90 and 0.97 (p = 0.07). The AUROCs for serum- and CSF-UCHL172 were 0.94 and 0.98 (p = 0.25).

CONCLUSION: Findings of this study demonstrate that CSF-UCHL1 measured immediately, 24, 48, and 72 h after ROSC is a valuable predictor for evaluating neurologic outcomes, whereas serum-UCHL1 measured at 24, 48, and 72 h after ROSC showed a significant performance in the prognostication of poor outcomes in post-OHCA patients treated with TTM.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Ahn HJ, Jung S, You Y, et al. The value of cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 protein as a prognostic predictor of neurologic outcome in post-cardiac arrest patients treated with targeted temperature management. Resuscitation. 2020. PMID: 32272234. doi:10.1016/j.resuscitation.2020.03.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。